Abstract:Genetically-encoded libraries (GEL) are increasingly used for discovery of ligands for ‘undruggable’ targets that cannot be addressed with small molecules. Foundational GEL platforms like phage-, yeast-, ribosome- and mRNA-display enabled display of libraries composed of 20 natural amino acids (20AA). Today, numerous strategies expand GEL beyond 20AA space by incorporating unnatural amino acids (UAA) and chemical post-translational modification (cPTM) to build linear, cyclic, and bicyclic peptides. The standard operating procedure for UAA and cPTM libraries starts from a "naïve" chemically-upgraded library with 108-1012 compounds, uses target of interest and rounds of selection to narrow down to a set of receptor binding hits. However, such approach uses zero knowledge of natural peptide-receptor interactions which already exists in libraries with 20AA space. There is currently no consensus whether ‘zero knowledge’ naïve libraries or libraries with pre-existing knowledge can offer a more effective path to discovery of molecular interactions. In this manuscript, we evaluated the feasibility of discovery of macrocyclic and bicyclic peptide from "non-zero knowledge" libraries. We approach this problem by late-stage chemical reshaping of phage-displayed landscape of 20AA binders to NS3aH1 protease. The re-shaping is performed under a novel multifunctional C2-symmetric linchpin, 3,5-bis(bromomethyl)benzaldehyde (termed KYL), that combines two electrophiles that react with thiols and aldehyde group that reacts with N-terminal amine. KYL diversified phage-displayed peptides into bicyclic architectures and delineates 2 distinct sequence populations: (i) peptides that retained binding upon bicyclization (ii) peptides that lost binding once chemically modified. Our report provides a case study for discovering advanced, chemically-upgraded macrocycles and bicycles from libraries with pre-existing knowledge. The results imply that thousands of selection campaigns completed in 20AA space, in principle, can serve for late-stage reshaping and as a starting point for discovery of advanced peptide-derived ligands.

Sortase-Mediated Peptide Ligation and Cyclization for Phage Display

Employing unnatural promiscuity of sortase to construct peptide macrocycle libraries for ligand discovery

Asparaginyl Endopeptidase-Mediated Peptide Ligation and Cyclization for Phage Display

N-Terminal cysteine mediated backbone-side chain cyclization for chemically enhanced phage display

A facile strategy for the construction of a phage display cyclic peptide library for the selection of functional macrocycles

Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

Proximity-driven site-specific cyclization of phage-displayed peptides

MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles

Use of Baculovirus MHC/peptide Display Libraries to Characterize T‐cell Receptor Ligands

Strategies for the Construction of Multicyclic Phage Display Libraries

Identification of Covalent Cyclic Peptide Inhibitors Targeting Protein-Protein Interactions Using Phage Display

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Phage Display of Two Distinct Warheads to Inhibit Challenging Proteins.

Late-stage reshaping of phage-displayed libraries to macrocyclic and bicyclic landscapes using multipurpose linchpin

Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry

Selection of Peptide-Bismuth Bicycles Using Phage Display

Design and Application of a DNA-Encoded Macrocyclic Peptide Library

Identification of highly selective covalent inhibitors by phage display

Display Technologies for Expanding the Pharmaceutical Applications of Cyclotides

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform